Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
23%
OVERLAP
BY WEIGHT
4
# OF OVERLAPPING
HOLDINGS
IHE
55
HOLDINGS
8%
ALSO IN OZEM
OZEM
21
HOLDINGS
19%
ALSO IN IHE
SECTOR DRIFT (IHE minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 24.0% | 18.2% | 18.2% |
|
PFIZER INC | 4.2% | 6.4% | 4.2% |
|
WAVE LIFE SCIENCES LTD. | 0.3% | 0.8% | 0.3% |
|
MBX BIOSCIENCES INC | 0.2% | 2.1% | 0.2% |
IHE Overweight Relative to OZEM
|
JOHNSON & JOHNSON | 20.1% |
|
ELI LILLY & CO | 5.8% |
|
ROYALTY PHARMA PLC CLASS A | 5.2% |
|
VIATRIS, INC. | 5.0% |
|
MERCK & CO. INC. | 4.4% |
|
BRISTOL-MYERS SQUIBB CO | 4.1% |
 |
JAZZ PHARMACEUTICALS PLC | 3.8% |
|
ELANCO ANIMAL HEALTH, INC. | 3.1% |
|
ZOETIS INC | 2.8% |
|
AXSOME THERAPEUTICS, INC. | 2.6% |
IHE Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -13.1% |
|
VIKING THERAPEUTICS, INC. | -4.8% |
 |
CHINA PHARMACEUTICAL GROUP | -4.5% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.3% |
|
ZEALAND PHARMA A/S | -4.1% |
 |
HANMI PHARM CO LTD | -4.0% |
 |
INNOVENT BIOLOGICS, INC. | -4.0% |
|
AMGEN INC | -3.5% |
 |
ASCLETIS PHARMA, INC. | -3.3% |
 |
ASTRAZENECA PLC | -3.3% |